was read the article
array:22 [ "pii" => "S0301054614000172" "issn" => "03010546" "doi" => "10.1016/j.aller.2013.11.002" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "581" "copyright" => "SEICAP" "copyrightAnyo" => "2013" "documento" => "article" "subdocumento" => "fla" "cita" => "Allergol Immunopathol (Madr). 2015;43:14-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1032 "formatos" => array:3 [ "EPUB" => 12 "HTML" => 699 "PDF" => 321 ] ] "itemSiguiente" => array:17 [ "pii" => "S0301054613002772" "issn" => "03010546" "doi" => "10.1016/j.aller.2013.08.003" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "567" "copyright" => "SEICAP" "documento" => "article" "subdocumento" => "fla" "cita" => "Allergol Immunopathol (Madr). 2015;43:19-24" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 955 "formatos" => array:3 [ "EPUB" => 13 "HTML" => 550 "PDF" => 392 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "19" "paginaFinal" => "24" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1141 "Ancho" => 1706 "Tamanyo" => 93573 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Frequency of causative drugs of the study subjects.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Y.H. Nam, M.R. Park, H.J. Nam, S.K. Lee, K.H. Kim, M.S. Roh, S.-J. Um, C.-H. Son" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Y.H." "apellidos" => "Nam" ] 1 => array:2 [ "nombre" => "M.R." "apellidos" => "Park" ] 2 => array:2 [ "nombre" => "H.J." "apellidos" => "Nam" ] 3 => array:2 [ "nombre" => "S.K." "apellidos" => "Lee" ] 4 => array:2 [ "nombre" => "K.H." "apellidos" => "Kim" ] 5 => array:2 [ "nombre" => "M.S." "apellidos" => "Roh" ] 6 => array:2 [ "nombre" => "S.-J." "apellidos" => "Um" ] 7 => array:2 [ "nombre" => "C.-H." "apellidos" => "Son" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0301054613002772?idApp=UINPBA00004N" "url" => "/03010546/0000004300000001/v1_201501250943/S0301054613002772/v1_201501250943/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "S0301054613001870" "issn" => "03010546" "doi" => "10.1016/j.aller.2013.06.002" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "532" "copyright" => "SEICAP" "documento" => "article" "subdocumento" => "fla" "cita" => "Allergol Immunopathol (Madr). 2015;43:10-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1159 "formatos" => array:3 [ "EPUB" => 14 "HTML" => 815 "PDF" => 330 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "The role of mean platelet volume as an inflammatory marker in children with chronic spontaneous urticaria" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "10" "paginaFinal" => "13" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A.Z. Akelma, E. Mete, M.N. Cizmeci, M.K. Kanburoglu, D.D. Malli, D. Bozkaya" "autores" => array:6 [ 0 => array:2 [ "nombre" => "A.Z." "apellidos" => "Akelma" ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Mete" ] 2 => array:2 [ "nombre" => "M.N." "apellidos" => "Cizmeci" ] 3 => array:2 [ "nombre" => "M.K." "apellidos" => "Kanburoglu" ] 4 => array:2 [ "nombre" => "D.D." "apellidos" => "Malli" ] 5 => array:2 [ "nombre" => "D." "apellidos" => "Bozkaya" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0301054613001870?idApp=UINPBA00004N" "url" => "/03010546/0000004300000001/v1_201501250943/S0301054613001870/v1_201501250943/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "A human monoclonal anti-TNF alpha antibody (adalimumab) reduces airway inflammation and ameliorates lung histology in a murine model of acute asthma" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "14" "paginaFinal" => "18" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "F. Catal, E. Mete, C. Tayman, E. Topal, A. Albayrak, H. Sert" "autores" => array:6 [ 0 => array:3 [ "nombre" => "F." "apellidos" => "Catal" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 1 => array:3 [ "nombre" => "E." "apellidos" => "Mete" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "C." "apellidos" => "Tayman" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:4 [ "nombre" => "E." "apellidos" => "Topal" "email" => array:1 [ 0 => "erdemtopal44@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 4 => array:3 [ "nombre" => "A." "apellidos" => "Albayrak" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 5 => array:3 [ "nombre" => "H." "apellidos" => "Sert" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Department of Pediatric Allergy and Asthma, Fatih University Faculty of Medicine, Ankara, Turkey" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Department of Pediatric Allergy and Asthma, Gazi University Faculty of Medicine, Ankara, Turkey" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Department of Pathology, Ankara Numune Education and Research Hospital, Ankara, Turkey" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Department of Anesthesia, Fatih University Faculty of Medicine, Ankara, Turkey" "etiqueta" => "d" "identificador" => "aff0020" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1385 "Ancho" => 2100 "Tamanyo" => 625015 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">(1a and 1b) Normal alveoli and bronchi (control group), H&E ×40 and ×100. (2a) Peri-bronchiolar and perivascular mix inflammation (asthma group), H&E ×40. (2b) Thickened alveolar walls with inflammation (asthma group), H&E ×100. (3a) The lung parenchyma without inflammation (adalimumab-treated group), H&E ×40. (3b) Mild thickened alveolar septa (adalimumab-treated group), H&E ×100.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Asthma is a chronic inflammatory disorder of the airways in which many cells and cellular elements play a role.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Asthma is a T helper 2 (Th2)-mediated disease characterised by increased airway eosinophilia, goblet cell hyperplasia with associated mucus production, neutrophilia and increased numbers of lung macrophages and activated mast cells.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> Additionally, cytokines play an important role in the aetiopathogenesis of asthma by promoting the development, differentiation, recruitment, activation and survival of inflammatory cells. TNF-alpha, which is a Th1 associated and pro-inflammatory cytokine with immunoregulatory activities, takes an important role in the aetiopathogenesis of asthma. TNF-alpha serves as a chemoattractant for the neutrophils and monocytes,<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> increases vascular permeability, and activates<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> T cells,<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> eosinophils<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,6</span></a> and mast cells. Few experimental studies in asthma have determined that different TNF-alpha blocking agents (anti-TNF antibody, recombinant human TNF receptor p80 Fc fusion protein) reduced the inflammation in the airways.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7,8</span></a> Additionally, data about the effects of human monoclonal anti-TNF alpha antibody seem to be limited. In the present study, the aim was to ascertain the effects of adalimumab (a human monoclonal anti-TNF alpha antibody) on lung histology and lung inflammation in a murine model of asthma.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Materials and methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Animals and experimental design</span><p id="par0010" class="elsevierStylePara elsevierViewall">BALB/c (H-2<span class="elsevierStyleSup">d/d</span>) female rats (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>18) were used for the study. Experimental protocols were approved by the Fatih University Animal Subject Committees. All animals were specified pathogen-free and were maintained under standard animal holding with water and food ad libitum at the Ankara D¿¿kap¿ Hospital, Research Center, Animals Research Laboratory in accordance with local and Turkish Home Office regulations. Twelve-week-old rats were randomly divided into three groups, including (group I) control (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>6) (Phosphate-buffered saline was implemented), (group II) asthma induced with OVA (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>6), and (group III) asthma induced with OVA<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>treated with adalimumab (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>6).</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Administration of OVA and adalimumab</span><p id="par0015" class="elsevierStylePara elsevierViewall">250<span class="elsevierStyleHsp" style=""></span>¿l of “Phosphate-buffered saline” (PBS) was given intraperitoneally to the rats in the control group on the first day and 14th day of the study. Additionally, rats were administered 250<span class="elsevierStyleHsp" style=""></span>¿l of PBS by intranasal route under anaesthesia (0.3<span class="elsevierStyleHsp" style=""></span>ml ketamine (6.5<span class="elsevierStyleHsp" style=""></span>mg/ml)/xylazine (0.44<span class="elsevierStyleHsp" style=""></span>mg/ml, intraperitoneally) on the 14th, 25th, 26th and 27th days of the study. Rats in groups I and II were sensitised with intraperitoneal 1<span class="elsevierStyleHsp" style=""></span>mg ovalbumin (OVA) (Sigma Co., St. Louis, MO) emulsified in 250<span class="elsevierStyleHsp" style=""></span>¿l of PBS on the first and the 14th day of the study; and 500<span class="elsevierStyleHsp" style=""></span>¿g OVA in 250<span class="elsevierStyleHsp" style=""></span>¿l of PBS by intranasal route (OVA challenge) was applied to the rats under anaesthesia (0.3<span class="elsevierStyleHsp" style=""></span>ml ketamine (6.5<span class="elsevierStyleHsp" style=""></span>mg/ml)/xylazine (0.44<span class="elsevierStyleHsp" style=""></span>mg/ml, intraperitoneally) on the 14th, 25th, 26th and 27th days of the study. Also, 100<span class="elsevierStyleHsp" style=""></span>¿g OVA in 100<span class="elsevierStyleHsp" style=""></span>¿l of PBS was given intraperitoneally to all rats one hour before each intranasal administration. Adalimumab with a dose of 5<span class="elsevierStyleHsp" style=""></span>mg/kg/day was applied intraperitoneally to the rats in the third group for five days, starting from the day before the first challenge. All rats were sacrificed by cervical dislocation on the 28th day of the study. Lung tissues were removed for the histopathological examination.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Lung histology and scoring</span><p id="par0020" class="elsevierStylePara elsevierViewall">The lung samples were fixed in 10% neutral buffered formalin, after the routine tissue monitorisation, the sections were obtained and stained with haematoxylin and eosin (H&E) and evaluated under light microscope. The lung sections from all groups were examined in a blinded fashion and lung inflammation was scored on the sections stained with H&E. All slides were evaluated over 10 consecutive fields at ×200 magnification. In order to be scored, each field had to contain a complete transection of at least one bronchiole less than half a field width in diameter, a blood vessel and an alveolar airway. Inflammatory cell infiltrate, i.e. the number and type of inflammatory cells present, was evaluated for the perivascular area, the bronchiolar epithelium and the peri-bronchiolar alveolar tissue. Inflammation was also scored on the basis of increased alveolar wall thickness. The scoring system used to assess inflammation is shown in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Statistical analysis</span><p id="par0025" class="elsevierStylePara elsevierViewall">Statistical analysis was performed by the Statistical Package for Social Sciences (SPSS) 15.0 software (SPSS Inc., Chicago, IL). Quantitative variables (lung score) were expressed in medians. The median score of groups were compared by using Kruskal–Wallis test. Mann–Whitney <span class="elsevierStyleItalic">U</span> test with Benferoni correction was used to evaluate the differences between groups. A two-sided <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05 was considered statistically significant.</p></span></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Results</span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Cell infiltration, inflammation and histological examination</span><p id="par0030" class="elsevierStylePara elsevierViewall">When compared with the normal controls, dense inflammation was seen in the perivascular and peribronchiolar areas, including lymphocytes and eosinophils infiltration; and interstitial space (alveoli walls) was severely thickened due to intense inflammation in the lung tissues of asthma induced rats (median score: 4, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.02). Bronchial smooth muscle hypertrophy and oedema were observed in the lung tissues of asthma induced rats. In the group treated with adalimumab, the number of inflammatory cells surrounding the bronchi and bronchioles and alveolar wall thickness had a similar histomorphological appearance with the control group (median score: 1, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.52). Furthermore, when compared, peribronchial smooth muscle hypertrophy and oedema were similar between the control group and the adalimumab-treated group (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). Statistically significant levels of the lung scores between the groups are shown in <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Discussion</span><p id="par0035" class="elsevierStylePara elsevierViewall">In the current study, we evaluated the effects of adalimumab (a human monoclonal anti-TNF alpha antibody) on the lung histology and lung inflammation in a murine model of asthma. We found that adalimumab treatment decreased the cell inflammation, and showed similar histological findings to the control group. These findings support the opinion that anti-TNF alpha antibody could be a promising agent in the treatment of asthma.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Asthma is a disease mediated by Th2 cells, and specific cytokines such as IL4, IL-5, and IL-13 have important roles in the aetiopathogenesis of asthma.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> TNF alpha, which is a Th1 lymphocyte-associated cytokine, has been shown to play an important role in the pathogenesis of asthma in the studies of both animals and humans.<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11,12</span></a> TNF-alpha, a strong pro-inflammatory cytokine, is mainly synthesised and stored by mast cells and alveolar macrophages in the lung, and it also has immune-regulatory properties.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> Furthermore, it contributes to the development of remodelling in asthma by affecting on fibroblasts and triggering the release of matrix metalloproteinase-9.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> Some studies on rats exposed to house dust and in patients with severe asthma have determined increased TNF-alpha expression in the airways.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,15,16</span></a> Therefore, some other studies have been conducted to ascertain the beneficial effects of TNF alpha inhibiting agents on both the animal models and patients with severe asthma. Additionally, some experimental studies have reported that agents inhibiting synthesis and activity of TNF-alpha decrease the infiltration of inflammatory cells in the airways.<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">17–19</span></a> However, these agents have been reported to be ineffective through some other studies.<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">20,21</span></a> Furthermore, results of these studies vary according to blocking of TNF alpha activities by different steps. Although Nam et al. have reported that using soluble TNF-alpha receptor in a rat model of asthma reduces eosinophil infiltration; they have declared that no beneficial effects have been found on the airway inflammation, when compared to the control group. In contrast, Kim et al.<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a> have determined in an experimental model of asthma that TNF alpha antibodies have provided significant improvement on the pulmonary inflammation, bronchial hyper-responsiveness and pulmonary histology.</p><p id="par0045" class="elsevierStylePara elsevierViewall">Recently, TNF alpha blocking agents have already been successfully used in the treatment of chronic diseases such as Crohn and Romatoid arthritis.<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a> Moreover, asthma is a chronic disease and TNF alpha is believed to have a major role in the pathogenesis of asthma. Therefore, TNF alpha blocking agents would provide favourable effects on the treatment of asthma. Some experimental studies related to asthma have unveiled the beneficial effects of TNF alpha blocking agents on the airway histology, cytokine levels in bronchoalveolar lavage (BAL), and bronchial hyper-responsiveness. However, few studies conducted on patients with severe asthma have indicated increased TNF alpha activity in BAL fluid and on the surface of peripheral blood monocytes.<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">15,24</span></a> These patients were administered Etanercept (a soluble fusion protein combining two identical chains of the human p75 TNF receptors with an Fc portion of human IgG1) for 12 weeks. At the end of the treatment session, improvement on the asthma symptoms such as bronchial hyper-responsiveness, and pulmonary function tests has been determined.</p><p id="par0050" class="elsevierStylePara elsevierViewall">All in all, asthma is a chronic disease of the airway, and it may sometimes have a severe nature and be treatment-resistant. TNF-alpha, a cytokine associated with Th1, is known to play an important role in the pathogenesis of asthma. It is also known that TNF-alpha blocking agents have beneficial effects on the airway inflammation, lung histology, and asthma symptoms. Adalimumab (a human monoclonal anti-TNF alpha antibody) is a different TNF alpha blocking agent. In the present study, we have evaluated the effects of adalimumab (a human monoclonal anti-TNF alpha antibody) on the lung histology and lung inflammation in a murine model of asthma. The work presented in the current study shows that adalimumab treatment suppresses the airway inflammation, and provides improvement in histological findings in asthma. We may suggest that adalimumab is a promising alternative for the treatment of patients with severe asthma which is unresponsive to treatment.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Conflicts of interest</span><p id="par0055" class="elsevierStylePara elsevierViewall">No competing financial interests exist and there is no conflicts of interest for each author.</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Ethical disclosures</span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Patients’ data protection</span><p id="par0065" class="elsevierStylePara elsevierViewall">Confidentiality of Data. The authors declare that no patient data appear in this article.</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Right to privacy and informed consent</span><p id="par0070" class="elsevierStylePara elsevierViewall">The authors declare that no patient data appear in this article.</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Protection of human subjects and animals in research</span><p id="par0075" class="elsevierStylePara elsevierViewall">The authors declare that the procedures followed were in accordance with the regulations of the responsible Clinical Research Ethics Committee and in accordance with those of the World Medical Association and the Helsinki Declaration.</p></span></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:2 [ "identificador" => "xres414317" "titulo" => array:5 [ 0 => "Abstract" 1 => "Background" 2 => "Method" 3 => "Result" 4 => "Conclusion" ] ] 1 => array:2 [ "identificador" => "xpalclavsec389957" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 3 => array:3 [ "identificador" => "sec0010" "titulo" => "Materials and methods" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Animals and experimental design" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Administration of OVA and adalimumab" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Lung histology and scoring" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Statistical analysis" ] ] ] 4 => array:3 [ "identificador" => "sec0035" "titulo" => "Results" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0040" "titulo" => "Cell infiltration, inflammation and histological examination" ] ] ] 5 => array:2 [ "identificador" => "sec0045" "titulo" => "Discussion" ] 6 => array:2 [ "identificador" => "sec0050" "titulo" => "Conflicts of interest" ] 7 => array:3 [ "identificador" => "sec0055" "titulo" => "Ethical disclosures" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0060" "titulo" => "Patients’ data protection" ] 1 => array:2 [ "identificador" => "sec0065" "titulo" => "Right to privacy and informed consent" ] 2 => array:2 [ "identificador" => "sec0070" "titulo" => "Protection of human subjects and animals in research" ] ] ] 8 => array:2 [ "identificador" => "xack123029" "titulo" => "Acknowledgements" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2013-07-19" "fechaAceptado" => "2013-11-14" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec389957" "palabras" => array:8 [ 0 => "Adalimumab" 1 => "Anti-TNF alpha" 2 => "Antibody" 3 => "Asthma" 4 => "Cytokine" 5 => "Inflammation" 6 => "Murine" 7 => "Ovalbumin" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span class="elsevierStyleSectionTitle" id="sect0010">Background</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A few experimental studies related to asthma have unveiled the beneficial effects of TNF alpha blocking agents on the airway histology, cytokine levels in bronchoalveolar lavage and bronchial hyper-responsiveness. In the current study, we aimed to assess the effect of adalimumab on the inflammation and histology of asthma in a murine model.</p> <span class="elsevierStyleSectionTitle" id="sect0015">Method</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Twelve-week-old BALB/c (H-2d/d) female rats (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>18) were allocated into three groups, including (group I) control (phosphate-buffered saline was implemented), (group II) asthma induced with OVA (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>6), and (group III) asthma induced with OVA<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>treated with adalimumab (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>6). Rats were executed on the 28th day of the study. The lung samples were fixed in 10% neutral buffered formalin. Lung parenchyma, alveolus, peribronchial and perivascular inflammation were assessed. Lung pathological scoring was performed.</p> <span class="elsevierStyleSectionTitle" id="sect0020">Result</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Severity of lung damage was found to be reduced significantly in the asthma induced with OVA<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>treated with adalimumab group. When compared with the untreated group, adalimumab significantly reduced the inflammatory cells around the bronchi and bronchioles, and reduced inflammation of the alveolar wall and alveolar wall thickness as well (median score<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.52). Peribronchial smooth muscle hypertrophy and oedema were significantly reduced after adalimumab administration.</p> <span class="elsevierStyleSectionTitle" id="sect0025">Conclusion</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Adalimumab (a human monoclonal anti-TNF alpha antibody) therapy significantly reduced the severity of lung damage by decreasing cellular infiltration and improvement on the lung histology in a murine model of acute asthma.</p>" ] ] "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1385 "Ancho" => 2100 "Tamanyo" => 625015 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">(1a and 1b) Normal alveoli and bronchi (control group), H&E ×40 and ×100. (2a) Peri-bronchiolar and perivascular mix inflammation (asthma group), H&E ×40. (2b) Thickened alveolar walls with inflammation (asthma group), H&E ×100. (3a) The lung parenchyma without inflammation (adalimumab-treated group), H&E ×40. (3b) Mild thickened alveolar septa (adalimumab-treated group), H&E ×100.</p>" ] ] 1 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col">Area scored (number of cells) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " colspan="4" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Score</th></tr><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">1 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">3 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">4 \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Perivascular compartment<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No infiltration \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><20 cells \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><100 cells \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">>100 cells \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Bronchiolar epithelium \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No infiltration \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><5 cells \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><10 cells \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">>10 cells \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Peri-bronchiolar alveolar tissue<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No infiltration \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><20 cells \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><100 cells \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">>100 cells \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Alveolar walls<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">c</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">No infiltration \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2–3 cells \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4–5 cells \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">>5 cells \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab646895.png" ] ] ] "notaPie" => array:3 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Cells around blood vessel walls.</p>" ] 1 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Defined as sub-bronchiolar tissue, beneath basement membrane and smooth muscle, not immediately adjacent to a blood vessel.</p>" ] 2 => array:3 [ "identificador" => "tblfn0015" "etiqueta" => "c" "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Scores indicative of focal expansion of alveolar walls by that number of cells.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Scoring system for assessing inflammation in a murine asthma model<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a></p>" ] ] 2 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Comparison of the groups \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Median lung score (min–max) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">P</span> value \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Group1, Group 2 & Group 3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (1–2), 4 (3–4) &1 (1–2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.001<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Group 1 & Group 2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (1–2) & 4 (3–4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.002<a class="elsevierStyleCrossRef" href="#tblfn0025"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Group 1 & Group 3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (1–2) & 1 (1–2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.523<a class="elsevierStyleCrossRef" href="#tblfn0025"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Group 2 & Group 3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4 (3–4) & 1 (1–2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.003<a class="elsevierStyleCrossRef" href="#tblfn0025"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab646896.png" ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tblfn0020" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0020"><span class="elsevierStyleItalic">p</span>: Kruskal–Wallis test.</p>" ] 1 => array:3 [ "identificador" => "tblfn0025" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0025"><span class="elsevierStyleItalic">p</span>: Mann–Whitney <span class="elsevierStyleItalic">U</span> test.</p> <p class="elsevierStyleNotepara" id="npar0030">Group 1: Control group, Group 2: Murine asthma model, Group 3: Murine asthma model-adalimumab treated group.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Comparison of the groups according to lung score.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:24 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "(GINA) 2011. Available from: <a href="http://www.ginasthma.org/">http://www.ginasthma.org</a>" ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pathology of asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.C. Hogg" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "1993" "volumen" => "92" "paginaInicial" => "1" "paginaFinal" => "5" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8335845" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "TNF-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "N.W. Lukacs" 1 => "R.M. Strieter" 2 => "S.W. Chensue" 3 => "M. Widmer" 4 => "S.L. Kunkel" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Immunol" "fecha" => "1995" "volumen" => "154" "paginaInicial" => "5411" "paginaFinal" => "5417" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7730642" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "TNF mediates lung leak, but not neutrophil accumulation, in lungs of rats given IL-1 intratracheally" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "B.M. Hybertson" 1 => "E.K. Jepson" 2 => "O.J. Cho" 3 => "J.H. Clarke" 4 => "Y.M. Lee" 5 => "J.E. Repine" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm.155.6.9196104" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "1997" "volumen" => "155" "paginaInicial" => "1972" "paginaFinal" => "1976" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9196104" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNFalpha-mediated enhancement of T cell responses" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "P. Scheurich" 1 => "B. Thoma" 2 => "U. Ucer" 3 => "K. Pfizenmaier" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Immunol" "fecha" => "1987" "volumen" => "138" "paginaInicial" => "1786" "paginaFinal" => "1790" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3029221" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "TNF alpha is important in human lung allergic reactions" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "T.B. Casale" 1 => "J.J. Costa" 2 => "S.J. Galli" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1165/ajrcmb.15.1.8679220" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Cell Mol Biol" "fecha" => "1996" "volumen" => "15" "paginaInicial" => "35" "paginaFinal" => "44" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8679220" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tumour necrosis factor-alpha blockade suppresses murine allergic airways inflammation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Hutchison" 1 => "B.S. Choo-Kang" 2 => "R.V. Bundick" 3 => "A.J. Leishman" 4 => "J.M. Brewer" 5 => "I.B. McInnes" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2249.2007.03509.x" "Revista" => array:6 [ "tituloSerie" => "Clin Exp Immunol" "fecha" => "2008" "volumen" => "151" "paginaInicial" => "114" "paginaFinal" => "122" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17931392" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anti-tumor necrosis factor-alpha antibody treatment reduces pulmonary inflammation and methacholine hyper-responsiveness in a murine asthma model induced by house dust" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Kim" 1 => "L. McKinley" 2 => "S. Natarajan" 3 => "G.L. Bolgos" 4 => "J. Siddiqui" 5 => "S. Copeland" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2222.2005.02407.x" "Revista" => array:6 [ "tituloSerie" => "Clin Exp Allergy" "fecha" => "2006" "volumen" => "36" "paginaInicial" => "122" "paginaFinal" => "132" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16393274" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "FITC-induced murine pulmonary inflammation: CC10 up-regulation and concurrent Shh expression" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C.E. Fisher" 1 => "S.A. Ahmad" 2 => "P.M. Fitch" 3 => "J.R. Lamb" 4 => "S.E. Howie" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cellbi.2005.07.002" "Revista" => array:6 [ "tituloSerie" => "Cell Biol Int" "fecha" => "2005" "volumen" => "29" "paginaInicial" => "868" "paginaFinal" => "876" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16150617" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Beta-arrestin-2 regulates the development of allergic asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.K. Walker" 1 => "A.M. Fong" 2 => "B.L. Lawson" 3 => "J.D. Savov" 4 => "D.D. Patel" 5 => "D.A. Schwartz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1172/JCI17265" "Revista" => array:6 [ "tituloSerie" => "J Clin Invest" "fecha" => "2003" "volumen" => "112" "paginaInicial" => "566" "paginaFinal" => "574" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12925697" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L.M. Teran" 1 => "M. Mochizuki" 2 => "J. Bartels" 3 => "E.L. Valencia" 4 => "T. Nakajima" 5 => "K. Hirai" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1165/ajrcmb.20.4.3508" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Cell Mol Biol" "fecha" => "1999" "volumen" => "20" "paginaInicial" => "777" "paginaFinal" => "786" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10101011" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "E.A. Garcia-Zepeda" 1 => "C. Combadiere" 2 => "M.E. Rothenberg" 3 => "M.N. Sarafi" 4 => "F. Lavigne" 5 => "Q. Hamid" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Immunol" "fecha" => "1996" "volumen" => "157" "paginaInicial" => "5613" "paginaFinal" => "5626" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8955214" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the humanmast cell as a source of these cytokines" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Bradding" 1 => "J.A. Roberts" 2 => "K.M. Britten" 3 => "M.N. Sarafi" 4 => "F. Lavigne" 5 => "Q. Hamid" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1165/ajrcmb.10.5.8179909" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Cell Mol Biol" "fecha" => "1994" "volumen" => "10" "paginaInicial" => "471" "paginaFinal" => "480" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8179909" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF alpha" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Schwingshackl" 1 => "M. Duszyk" 2 => "N. Brown" 3 => "R. Moqbel" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "1999" "volumen" => "104" "paginaInicial" => "983" "paginaFinal" => "989" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10550743" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tumour necrosis factor (TNF alpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.H. Howarth" 1 => "K.S. Babu" 2 => "H.S. Arshad" 3 => "L. Lau" 4 => "M. Buckley" 5 => "W. McConnell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/thx.2005.045260" "Revista" => array:6 [ "tituloSerie" => "Thorax" "fecha" => "2005" "volumen" => "60" "paginaInicial" => "1012" "paginaFinal" => "1018" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16166100" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Human antitumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.B. Hanauer" 1 => "W.J. Sandborn" 2 => "P. Rutgeerts" 3 => "R.N. Fedorak" 4 => "M. Lukas" 5 => "D. MacIntosh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.gastro.2005.11.030" "Revista" => array:6 [ "tituloSerie" => "Gastroenterology" "fecha" => "2006" "volumen" => "130" "paginaInicial" => "323" "paginaFinal" => "333" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16472588" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "C. Zuany-Amorim" 1 => "S. Haile" 2 => "D. Leduc" 3 => "C. Dumarey" 4 => "M. Huerre" 5 => "B.B. Vargaftig" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1172/JCI117966" "Revista" => array:6 [ "tituloSerie" => "J Clin Invest" "fecha" => "1995" "volumen" => "95" "paginaInicial" => "2644" "paginaFinal" => "2651" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7769104" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L.M. Renzetti" 1 => "P.M. Paciorek" 2 => "S.A. Tannu" 3 => "C. Dumarey" 4 => "M. Huerre" 5 => "B.B. Vargaftig" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Pharmacol Exp Ther" "fecha" => "1996" "volumen" => "278" "paginaInicial" => "847" "paginaFinal" => "853" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8768739" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.J. Elliott" 1 => "R.N. Maini" 2 => "M. Feldmann" 3 => "A. Long-Fox" 4 => "P. Charles" 5 => "P. Katsikis" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "1993" "volumen" => "36" "paginaInicial" => "1681" "paginaFinal" => "1690" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8250987" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Modulation of allergic inflammation in mice deficient in TNF receptors" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "D.G. Rudmann" 1 => "M.W. Moore" 2 => "J.S. Tepper" 3 => "M.C. Aldrich" 4 => "J.W. Pfeiffer" 5 => "H. Hogenesch" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Physiol-Lung Cell Mol Physiol" "fecha" => "2000" "volumen" => "279" "paginaInicial" => "1047" "paginaFinal" => "1057" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E.M. Hessel" 1 => "A.J. Van Oosterhout" 2 => "I. Van Ark" 3 => "M.C. Aldrich" 4 => "J.W. Pfeiffer" 5 => "H. Hogenesch" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1165/ajrcmb.16.3.9070618" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Cell Mol Biol" "fecha" => "1997" "volumen" => "16" "paginaInicial" => "325" "paginaFinal" => "334" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9070618" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The soluble tumor necrosis factor-alpha receptor suppresses airway inflammation in a murine model of acute asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H.S. Nam" 1 => "S.Y. Lee" 2 => "S.J. Kim" 3 => "J.S. Kim" 4 => "S.S. Kwon" 5 => "Y.K. Kim" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3349/ymj.2009.50.4.569" "Revista" => array:6 [ "tituloSerie" => "Yonsei Med J" "fecha" => "2009" "volumen" => "50" "paginaInicial" => "569" "paginaFinal" => "575" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19718408" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Feldman" 1 => "P. Taylor" 2 => "E. Paleolog" 3 => "F.M. Brennan" 4 => "R.N. Maini" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Transplant Proc" "fecha" => "1998" "volumen" => "30" "paginaInicial" => "4126" "paginaFinal" => "4127" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9865320" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evidence of a role of tumor necrosis factor alpha in refractory asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.A. Berry" 1 => "B. Hargadon" 2 => "M. Shelley" 3 => "D. Parker" 4 => "D.E. Shaw" 5 => "R.H. Green" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa050580" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2006" "volumen" => "354" "paginaInicial" => "697" "paginaFinal" => "708" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16481637" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack123029" "titulo" => "Acknowledgements" "texto" => "<p id="par0080" class="elsevierStylePara elsevierViewall">The authors thank Tuncay Delibas¿, M.D., and the Ankara D¿¿kap¿ Hospital, Research Center, Animals Research Laboratory's workers for providing help in nursing, immunisation with OVA and sacrificing of animals.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/03010546/0000004300000001/v1_201501250943/S0301054614000172/v1_201501250943/en/main.assets" "Apartado" => array:4 [ "identificador" => "5554" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/03010546/0000004300000001/v1_201501250943/S0301054614000172/v1_201501250943/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0301054614000172?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 1 | 5 |
2024 October | 36 | 11 | 47 |
2024 September | 44 | 11 | 55 |
2024 August | 51 | 7 | 58 |
2024 July | 38 | 8 | 46 |
2024 June | 34 | 12 | 46 |
2024 May | 35 | 8 | 43 |
2024 April | 42 | 8 | 50 |
2024 March | 40 | 4 | 44 |
2024 February | 27 | 7 | 34 |
2024 January | 405 | 4 | 409 |
2023 December | 19 | 15 | 34 |
2023 November | 17 | 12 | 29 |
2023 October | 32 | 10 | 42 |
2023 September | 16 | 3 | 19 |
2023 August | 29 | 8 | 37 |
2023 July | 30 | 24 | 54 |
2023 June | 30 | 2 | 32 |
2023 May | 50 | 9 | 59 |
2023 April | 47 | 2 | 49 |
2023 March | 23 | 8 | 31 |
2023 February | 15 | 9 | 24 |
2023 January | 14 | 17 | 31 |
2022 December | 24 | 8 | 32 |
2022 November | 22 | 11 | 33 |
2022 October | 23 | 17 | 40 |
2022 September | 23 | 18 | 41 |
2022 August | 45 | 15 | 60 |
2022 July | 32 | 5 | 37 |
2022 June | 33 | 13 | 46 |
2022 May | 40 | 12 | 52 |
2022 April | 64 | 16 | 80 |
2022 March | 102 | 27 | 129 |
2022 February | 106 | 8 | 114 |
2022 January | 69 | 5 | 74 |
2021 December | 74 | 8 | 82 |
2021 November | 56 | 8 | 64 |
2021 October | 43 | 11 | 54 |
2021 September | 31 | 10 | 41 |
2021 August | 46 | 6 | 52 |
2021 July | 14 | 7 | 21 |
2021 June | 17 | 10 | 27 |
2021 May | 32 | 8 | 40 |
2021 April | 63 | 18 | 81 |
2021 March | 21 | 14 | 35 |
2021 February | 13 | 19 | 32 |
2021 January | 10 | 2 | 12 |
2020 November | 0 | 1 | 1 |
2020 September | 0 | 2 | 2 |
2020 August | 0 | 1 | 1 |
2020 July | 0 | 1 | 1 |
2020 May | 0 | 2 | 2 |
2020 April | 0 | 3 | 3 |
2020 March | 0 | 3 | 3 |
2020 February | 0 | 6 | 6 |
2020 January | 0 | 1 | 1 |
2019 December | 0 | 1 | 1 |
2019 November | 0 | 2 | 2 |
2019 October | 0 | 2 | 2 |
2019 August | 0 | 3 | 3 |
2019 July | 0 | 7 | 7 |
2019 June | 0 | 1 | 1 |
2019 May | 0 | 10 | 10 |
2019 April | 0 | 6 | 6 |
2019 March | 0 | 2 | 2 |
2019 February | 0 | 3 | 3 |
2018 March | 4 | 0 | 4 |
2018 February | 14 | 6 | 20 |
2018 January | 15 | 2 | 17 |
2017 December | 24 | 4 | 28 |
2017 November | 13 | 5 | 18 |
2017 October | 22 | 5 | 27 |
2017 September | 8 | 10 | 18 |
2017 August | 23 | 13 | 36 |
2017 July | 18 | 7 | 25 |
2017 June | 30 | 28 | 58 |
2017 May | 31 | 18 | 49 |
2017 April | 34 | 14 | 48 |
2017 March | 20 | 22 | 42 |
2017 February | 25 | 3 | 28 |
2017 January | 15 | 9 | 24 |
2016 December | 34 | 5 | 39 |
2016 November | 40 | 6 | 46 |
2016 October | 41 | 12 | 53 |
2016 September | 43 | 6 | 49 |
2016 August | 39 | 4 | 43 |
2016 July | 32 | 6 | 38 |
2016 June | 31 | 12 | 43 |
2016 May | 18 | 9 | 27 |
2016 April | 35 | 16 | 51 |
2016 March | 35 | 14 | 49 |
2016 February | 29 | 13 | 42 |
2016 January | 21 | 14 | 35 |
2015 October | 0 | 1 | 1 |
2015 May | 0 | 1 | 1 |
2015 April | 1 | 6 | 7 |
2015 March | 1 | 2 | 3 |
2015 February | 3 | 8 | 11 |